Berlin, June 19 (CNA) French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan's reservoirs down to 3 months' water supply: Agency
03/28/2024 08:18 PM - Society
MOTC approves Danhai light rail 2nd phase plan
03/28/2024 06:58 PM - Society
Basketball star Quincy Davis gets 1-month sentence for domestic violence
03/28/2024 06:13 PM - Culture
Second leg of Yoshitomo Nara art tour to open in Penghu Friday
03/28/2024 05:51 PM - Sports
Young boxing league breathes new life into Taiwan sport scene
03/28/2024 04:52 PM